Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Ipilimumab and Imatinib Mesylate in Advanced Cancer (NCT01738139)M.D. Anderson Cancer Center2013-02-19
Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients (NCT01440582)M.D. Anderson Cancer Center2013-02-18
Single Dose Escalation Study of GSK2838232 in Healthy Subjects (NCT01802918)GlaxoSmithKline2013-02-18
Translational and Clinical Aspects of Metabolic, Anabolic and Endothelial Dysfunction in Heart Failure (NCT05277415)Lars Lund2013-02-17
Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery (NCT01787500)M.D. Anderson Cancer Center2013-02-15
Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet Injector (NCT01765426)Takeda2013-02-15
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer (NCT01727076)National Cancer Institute (NCI)2013-02-15
Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas (NCT01794104)National Cancer Institute (NCI)2013-02-15
Study of Labetuzumab Govitecan in Participants With Metastatic Colorectal Cancer (NCT01605318)Gilead Sciences2013-02-12
Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma (NCT01767454)GlaxoSmithKline2013-02-12
1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat (NCT03399526)Bayer2013-02-11
Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B (NCT01687608)Baxalta now part of Shire2013-02-11
Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma (NCT01740297)Amgen2013-02-07
A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast Patients (NCT01795586)H. Lee Moffitt Cancer Center and Research Institute2013-02-06
SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients (NCT01749969)Sanofi2013-02-06
Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate (NCT01792687)Aragon Pharmaceuticals, Inc.2013-02-05
A Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor Malignancies (NCT01725100)GlaxoSmithKline2013-02-05
BAY86-9766 Plus Gemcitabine Phase I Study in Asian (NCT01764828)Bayer2013-02-05
Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma (NCT01711554)National Cancer Institute (NCI)2013-02-04
Investigation of Potential Drug-drug Interaction of Volasertib With Itraconazole in Patients With Various Tumours (NCT01772563)Boehringer Ingelheim2013-02-04
Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM (NCT01811498)Northwell Health2013-02-01
Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer (NCT01783951)Capital Medical University2013-02-01
Sinovuyo Caring Families Project - Pilot Trial (NCT01802294)University of Cape Town2013-02-01
Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children (NCT01652287)Georgetown University2013-02-01
Smartphone Technology and CBT-GSH in Binge Eaters (NCT02399982)Icahn School of Medicine at Mount Sinai2013-02-01
PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects. (NCT01664221)Azidus Brasil2013-02-01
A Study of RO5503781 as a Single Agent or in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (NCT01773408)Hoffmann-La Roche2013-02-01
An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic Impairment (NCT01790607)Ono Pharma USA Inc2013-02-01
Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide (NCT01604031)Baylor College of Medicine2013-02-01
Treatment of Chronic Fatigue Syndrome (CFS) With Iodinated Activated Charcoal (IodoCarb®) (NCT01793415)PharmaLundensis AB2013-02-01
Safety, Pharmacokinetics, Pharmacodynamics, and Disintegration Time of Vaginal Tablets Containing Tenofovir and/or Emtricitabine (NCT01694407)CONRAD2013-02-01
A Study to Assess the Pharmacokinetics of Ceftaroline in End Stage Renal Disease Patients and Matched Healthy Subjects (NCT01664065)Pfizer2013-02-01
Detection of Functioning Pituitary Microadenoma: PET/MRI Versus PET/CT (NCT03404414)Peking Union Medical College Hospital2013-02-01
Radiofrequency Probe for Management of Unresectable Bile Duct and Pancreatic Cancer (NCT02042859)Ochsner Health System2013-02-01
The Effect of Probiotics on Non Alcoholic Fatty Liver Disease (NCT00808990)Rabin Medical Center2013-02-01
RCT for Women With a Persisting Pregnancy of Unknown Location (NCT01800162)University of Pennsylvania2013-02-01
IV NSAI Versus Nebulized Morphine Analgesia for First-line Renal Colic (NCT02156596)University of Monastir2013-02-01
Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer. (NCT01929486)Aichi Medical University2013-02-01
Self Assembling Peptide P11-4 in Patients With Early Occlusal Carious Lesions (NCT02724592)University Medicine Greifswald2013-02-01
Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects (NCT01768455)LG Life Sciences2013-02-01
Non-Significant Risk Feasibility Study to Assess Retention and Replacement of the OTX Punctum Plug (NCT01800175)Ocular Therapeutix, Inc.2013-02-01
Safety Study on IdeS in Healthy Volounteers (NCT01802697)Hansa Biopharma AB2013-02-01
ANX-188 Thorough QT/QTc Study in Healthy Volunteers (NCT01790087)Mast Therapeutics, Inc.2013-02-01
Phase I Study of LB-100 With Docetaxel in Solid Tumors (NCT01837667)Lixte Biotechnology Holdings, Inc.2013-02-01
PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (SUBCUTANEOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS (NCT01652638)Azidus Brasil2013-02-01
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis (NCT01789320)Clearside Biomedical, Inc.2013-02-01
A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Methotrexate (NCT01884636)Astellas Pharma Global Development, Inc.2013-02-01
Safety, Pharmacokinetic, and Pharmacodynamic Study of NKTT120 in Adult Patients With Stable Sickle Cell Disease (SCD) (NCT01783691)NKT Therapeutics2013-02-01
Pharmacokinetic of Alirocumab SAR236553 (REGN727) Administered Subcutaneously at 3 Different Injection Sites in Healthy Subjects (NCT01785329)Sanofi2013-02-01
QOL, ADL and Pain Before and After Intervention With N3 From Krill With D3. (NCT02008760)Hospitalet Valdemar2013-02-01
Newer Antidepressants in Combination With Pregabalin for Fibromyalgia Syndrome (NCT02451475)Mansoura University2013-02-01
A Study to Evaluate the Safety, Tolerance, and Pharmacokinetic and Pharmacodynamic Profile Of 1 SR Formulation of EB-1020 (NCT01744808)Otsuka Pharmaceutical Development & Commercialization, Inc.2013-02-01
A Safety Study of SGN-CD19A for B-Cell Lymphoma (NCT01786135)Seagen Inc.2013-02-01
A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis (NCT01789242)Criterium, Inc.2013-02-01
A Study of Combined Deferasirox, Vitamin D and Azacytidine in High Risk MDS (NCT01718366)Groupe Francophone des Myelodysplasies2013-02-01
The Safety of Tuberculosis Treatments by Oral Inhalation (NCT01785927)Prince of Songkla University2013-02-01
A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Abusers (NCT01746901)Pfizer2013-02-01
Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm (NCT01803477)LEO Pharma2013-02-01
Ipilimumab and Local Radiation for Selected Solid Tumors (NCT01769222)Stanford University2013-02-01
PK and PD Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects (NCT01664195)Azidus Brasil2013-02-01
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects (NCT01813448)Astellas Pharma Global Development, Inc.2013-02-01
Pharmacokinetics of Sildenafil in Premature Infants (NCT01670136)University of North Carolina, Chapel Hill2013-02-01
Functionality of Male Condoms With a Silicone Elastomer Vaginal RIng (NCT01755741)International Partnership for Microbicides, Inc.2013-02-01
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma (NCT01409174)M.D. Anderson Cancer Center2013-02-01
PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (INTRAVENOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS (NCT01651923)Azidus Brasil2013-02-01
A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes (NCT01784211)Eli Lilly and Company2013-02-01
A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Metformin (NCT01884558)Astellas Pharma Global Development, Inc.2013-02-01
Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment (NCT02034669)Tri Phuoc Biotechnology., JSC2013-02-01
Carisbamate as a Potential Treatment for Alcohol Dependence (NCT02435381)Baylor College of Medicine2013-02-01
Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease (NCT02594839)Federal Research Clinical Center of Federal Medical & Biological Agency, Russia2013-02-01
HIV Prevention for HIV-Negative Men Via Reduction of Social Anxiety (NCT02045225)Toronto Metropolitan University2013-02-01
Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis (NCT01759056)Avaxia Biologics, Incorporated2013-02-01
Effects of Cerebellum or Supplementary Motor Area Functional Inactivation on Gait and Balance Control (NCT02976298)Institut National de la Santé Et de la Recherche Médicale, France2013-02-01
Mindfulness and Acceptance Applied in Colleges Through Web-Based Guided Self-Help (NCT01808404)Contextual Change LLC2013-02-01
Investigation of Faldaprevir Effect on Pharmacokinetics of Raltegravir (NCT01785160)Boehringer Ingelheim2013-02-01
A Study to Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Male Subjects (NCT02083627)Astellas Pharma Europe B.V.2013-02-01
A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007 (NCT01929070)Hanmi Pharmaceutical Company Limited2013-02-01
Study of the Acute Effects of Triheptanoin in Heart Failure (NCT01787851)University of Texas Southwestern Medical Center2013-02-01
A Phase I In-Vivo Peptide Applied in the Right Colon (NCT01722058)University of Michigan2013-02-01
Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 Days (NCT01786915)Stealth BioTherapeutics Inc.2013-02-01
Autoinjector Device Assessment Study (NCT02349802)AstraZeneca2013-02-01
A Pilot Study of Minocycline in Intracerebral Hemorrhage Patients (NCT01805895)Augusta University2013-02-01
Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders (NCT01540292)University of Liege2013-02-01
Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed Meningitis (NCT01554124)PENTA Foundation2013-02-01
Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall (NCT00826085)Imunon2013-02-01
A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years (NCT01789086)Novo Nordisk A/S2013-02-01
A Safety Study of SGN-CD19A for Leukemia and Lymphoma (NCT01786096)Seagen Inc.2013-02-01
The Effect of Mixed Exercise and Metabolic Stress in Relationship to Age in Healthy Men (NCT01800370)Mayo Clinic2013-02-01
Using EEG Operant Conditioning to Improve Trait Self-Control and Promote Healthy Behavior (NCT01801254)University of Rochester2013-02-01
Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin (NCT01795937)Boehringer Ingelheim2013-02-01
Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD) (NCT01707225)Virginia Commonwealth University2013-02-01
An Open-Label, Single- and Multi-Dose Pharmacokinetic (PK) Study of Oral Diltiazem and Topical Diltiazem Hydrochloride (NCT01816191)Ventrus Biosciences, Inc2013-02-01
PET Imaging of Extrathalamic α4β2-nicotinic Acetylcholine Receptors in Health and Disease With [18F]XTRA (NCT01894646)Johns Hopkins University2013-02-01
Incentive Spirometry and Breath Stacking (NCT02054039)Federal University of São Paulo2013-02-01
Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors (NCT01751308)Sanofi2013-02-01
Applicability Clinic of Cement Portland Structural White in Endodontic Surgery (NCT02474615)Universidade do Vale do Sapucai2013-02-01
A Drug-Drug Interaction Study of the Effect of Rabeprazole, Itraconazole or Fluconazole on the Pharmacokinetics of Vismodegib (NCT01772290)Genentech, Inc.2013-02-01
A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations (NCT02249936)Ardelyx2013-02-01
Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder Carcinoma (NCT01878188)Anchiano Therapeutics Israel Ltd.2013-02-01
To Evaluate the Effect of Ritonavir or Omeprazole on the Pharmacokinetics of Samatasvir (IDX719) in Healthy Participants (MK-1894-006) (NCT01813552)Merck Sharp & Dohme LLC2013-02-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.